CD274 and melanoma: Similarly, Ligtenberg et al. applied RNAi to downregulate PD-1 in T cells, indirectly reducing PD-L1 signaling, which led to enhanced adoptive T cell therapy responses in melanoma and increased T cell capacity to secrete IFN-γ upon polyclonal stimulation [74].